Extended-release buprenorphine is approved as a once-monthly subcutaneous injection for the treatment of moderate-to-severe ...
The "Constipation Treatment - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.The global market for Constipation Treatment was valued at US$19.5 Billion in 2024 ...
The true figure, as recorded by the US public health authority, the CDC, is indeed alarming, but it is much lower than this.
U.S. health officials like Robert F. Kennedy Jr. tout San Patrignano, Europe's best-known rehab center, as a "beautiful model ...
Individuals with gout are more likely than those without the disease to receive chronic opioid therapy, independent of other ...
Non-opioid analgesic shows efficacy in several animal pain models, including diabetic and chemotherapy-induced neuropathic pain Compelling safety and pharmacokinetic profiles in animals support IND-en ...
Non-opioid analgesic shows efficacy in several animal pain models, including diabetic and chemotherapy-induced neuropathic painCompelling safety ...
Amanda Eleazar, of Iowa City, was just 25 years old when she started using opioids. It was 2014, and she was a mother of four ...
BOCA RATON, Fla.-- (BUSINESS WIRE)--December 15, 2025-- ...
Other hospitals across the country have modeled their own youth opioid treatment programs after the one at Valley Medical ...
SereNeuro Therapeutics, a preclinical biotechnology company developing non-opioid pain therapies, has unveiled new data on a ...
Washington State University researchers have discovered how a neural circuit – or a connection between two brain regions – drives relapse after opioid use, a finding that could lead to more effective ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results